Identification of in vitro immunogenicT-cell epitopes is important for the design of immunotherapeutics targeted to specific antigenic sites. To identify candidate cytotoxic T-lymphocyte (CTL) epitopes in the protease of human immunodeficiency virus type 1 (HIV-1) strain MN, we synthesized 9-mer and 10- mer peptides containing the HLA-A*0201 binding motif. Binding affinity of the peptides was measured by HLA-A*0201 up-regulation on T2 cells. Peptides with high binding-affinity were tested for their ability to stimulate primary CTLs from healthy HIVnegative blood donors. Peptide-specific CTLs were obtained from five out of six donors by stimulation with a 9-mer (LVGPTPVNI) or a 10-mer (VLVGPTPVNI) peptide derived from a highly conserved amino acid stretch in the C-terminal region of the protease. Addition of peptide-specific CTLs to acutely HIV-infected lymphocytes resulted in inhibition of p24gag production. In conclusion, a highly conserved HIV protease peptide regularly elicits peptide-specific CTLs. Targeting immune responses against defined epitopes in non-variable regions may be a feasible way to minimize the risk of virus escape from immune surveillance.
CocchiF.,
De VicoA. L.,
Garzino-DemoA.,
AryaS. K.,
GalloR. C.,
LussoP.1995; Identification of RANTES, MIP-1α and MIP-1α as major HIV-suppressive factors produced by CD8+ T cells. Science 27:1811–1815
CouillinI.,
ConnanF.,
CulmannpenciolelliB.,
GomardE.,
GuilletJ. G.,
ChoppinJ.1995; HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide HLA binding. European Journal of Immunology 25:728–732
del GuercioM. F.,
SidneyJ.,
HermansonG.,
PerezC.,
GreyH. M.,
KuboR. T.,
SetteA.1995; Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. Journal of Immunology 154:685–693
DemariaA.,
CirilloC.,
MorettaL.1994; Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. Journal of Infectious Diseases 170:1296–1299
GotchF.,
RothbardJ.,
HowlandK.,
TownsendA.,
McMichaelA.1987; Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326:881–882
HarrerE.,
HarrerT.,
BarbosaP.,
FeinbergM.,
JohnsonR. P.,
BuchbinderS.,
WalkerB. D.1996a; Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. Journal of Infectious Diseases 173:476–479
HoM.,
ArmstrongJ.,
McMahonD.,
PazinG.,
HuangX. L.,
RinaldoC.,
WhitesideT.,
TripoliC.,
LevineG.,
MoodyD.
others 1993; A phase 1 study of adoptive transfer of autologous CD8 + T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. Blood 81:2093–2101
HsuehF. W.,
WalkerC. M.,
BlackbournD. J.,
LevyJ. A.1994; Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cellular Immunology 159:271–279
IrwinM. J.,
HeathW. R.,
ShermanL. A.1989; Species restricted interactions between CD8 and a3 domain of class I influence the magnitude of xenogenic response. Journal of Experimental Medicine 170:1091–1101
KageyamaS.,
TsomidesT. J.,
SykulevY.,
EisenH. N.1995; Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. Journal of Immunology 154:567–576
KastW. M.,
BrandtR. M.,
SidneyJ.,
DrijfhoutJ. W.,
KuboR. T.,
GreyH. M.,
MeliefC. J.,
SetteA.1994; Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. Journal of Immunology 152:3904–3912
KoupR. A.,
SafritJ. T.,
CaoY. Z.,
AndrewsC. A.,
McLeodG.,
BorkowskyW.,
FarthingC.,
HoD. D.1994; Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68:4650–4655
LamhamedicherradiS.,
CulmannpenciolelliB.,
GuyB.,
LyT. D.,
GoujardC.,
GuilletJ. G.,
GomardE.1995; Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9:421–426
LangladeD. P.,
Ngo-Giang-HuongN.,
FerchalF.,
OksenhendlerE.1994; Human immunodeficiency virus (HIV) Nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. Journal of Clinical Investigation 93:1293–1297
MacatoniaS. E.,
PattersonS.,
KnightS. C.1991; Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology 74:399–406
MackewiczC. E.,
BlackbournD. J.,
LevyJ. A.1995; CD8 + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences, USA 92:2308–2312
MossP.,
Rowland-JonesS. L.,
FrodshamP. M.,
McAdamS.,
GiangrandeP.,
McMichaelA. J.,
BellJ. I.1995; Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proceedings ofthe National Academy of Sciences, USA 92:5773–5777
MyersG.,
Wain-HobsonS.,
HendersonL. E.,
KorberB.,
Kuan-TehJ.,
PavlakisG. N.1996Compilation and analysis of nucleic acid and amino acid sequences. Human retroviruses and AIDS Theoretical Biology and Biophysics, Los Alamos National Library, Los Alamos, New Mexico, USA: Internet location: http://hiv-web.lanl.gov/
PhillipsR. E.,
Rowland-JonesS. L.,
NixonD. F.,
GotchF. M.,
EdwardsJ. P.,
OgunlesiA. O.,
ElvinJ. G.,
RothbardJ. A.,
BanghamC. R.,
RizzaC. R.
others 1991; Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453–459
PintoL. A.,
SullivanJ.,
BerzofskyJ. A.,
ClericiM.,
KesslerH. A.,
LandayA. L.,
ShearerG. M.1995; Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. Journal of Clinical Investigation 96:867–876
RessingM. E.,
SetteA.,
BrandtR. M.,
RuppertJ.,
WentworthP. A.,
HartmanM.,
OseroffC.,
GreyH. M.,
MeliefC. J.,
KastW. M.1995; Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. Journal of Immunology 154:5934–5943
Rowland-JonesS. L.,
McMichaelA.1995; Immune responses in HIV-exposed seronegatives - have they repelled the virus?. Current Opinion in Immunology 7:448–455
StuberG.,
DillnerJ.,
ModrowS.,
WolfH.,
SzekelyL.,
KleinG.,
KleinE.1995; HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. International Immunology 7:653–663
SundqvistV. A.,
AlbertJ.,
OhlssonE.,
HinkulaJ.,
FenyöE. M.,
WahrenB.1989; Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. Journal of Medical Virology 29:170–175
TsubotaH.,
LordC. I.,
WatkinsD. I.,
MorimotoC.,
LetvinN. L.1989; A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. Journal of Experimental Medicine 169:1421–1434
VanderburgS. H.,
KleinM. R.,
VandeveldeC.,
KastW. M.,
MiedemaF.,
MeliefC.1995; Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121–127
VitielloA.,
IshiokaG.,
GreyH. M.,
RoseR.,
FarnessP.,
LaFondR.,
YuanL.,
ChisariF. V.,
FurzeJ.,
BartholomeuzR.
others 1995; Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. Journal of Clinical Investigation 95:341–349
WalkerB. D.,
FlexnerC.,
ParadisT. J.,
FullerT. C.,
HirschM. S.,
SchooleyR. T.,
MossB.1988; HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64–66